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ABSTRACT
Background and study aims Traditionally in the case of a
vascular interposition, endoscopic ultrasound-guided fine-
needle aspiration (EUS-FNA) has been contraindicated. A
transvascular route (TV) is feasible and probably a safe al-
ternative approach in selected patients, but data are scarce.
The primary aim of this study was to analyze the diagnostic
yield and safety of EUS-TV-FNA in thoracic and abdominal
lesions. Secondary aims included evaluation of the clinical
impact and technical aspects.
Patients and methods A retrospective multicenter study
was conducted with inclusion of all consecutive patients
that underwent EUS-TV-FNA from July 2007 to January
2020. Feasibility, cytopathology, procedure details, and
safety were evaluated. Univariate analysis was performed
to identify variables associated with incidents, cytopatholo-
gical diagnosis, and clinical impact.
Results Data were collected from a total of 49 cases and 50
EUS-TV-FNAs. The aorta (n =19) and portal system (n=17)
were the most frequently punctured. The most frequent le-
sions were mediastinal lymph nodes (n =13) and pancreatic
tumors (n =11). The diagnostic yield was 86%, and there
were nondiagnostic samples in seven cases. Overall sensi-
tivity, specificity, and accuracy were 88% (95%CI,0.74–
0.96), 100% (95%CI,0.59–1), and 90% (95%CI,0.78–0.96),
respectively. Only three incidents were detected: two mural
hematomas and a self-limited bleeding of gastroduodenal
artery. In most patients, there was a significant impact on
clinical management (88%). Arterial vessel and ASA-III had
a trend with incidents (both, P<0.08). Rapid on-site evlaua-
tion was found to be an independent predictor for obtain-
ing a conclusive sample (OR 6.2; 95%CI, 1.06–36.73, P <
0.04).
Conclusions EUS-TV-FNA is feasible, seems to be safe, and
can be recommended when no other targets are available,
and the information obtained would impact on the clinical
plan.
Supplementary material is available under
https://doi.org/10.1055/a-1288-0030
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Introduction
Sometimes a major vessel is interposed between the target le-
sion and the echoendoscope. Lesions of this kind are classically
considered to be beyond the reach of the endosonographer.
Historically, the transvascular approach has been avoided
because of concerns about bleeding, but the previous experi-
ence of radiologists has shown that traversing major vascular
structures adjacent to the target biopsy site (i. e., aorta, cava,
porta) does not increase the risk of adverse events (AEs) and
should be considered when the result of the biopsy will affect
the clinical strategy of patient care [1–3].
In recent years, a slow proliferation of studies regarding
endoscopic ultrasound (EUS) and endobronchial ultrasound
bronchoscopy (EBUS-guided transvascular biopsies, especially
of intrathoracic lesions, has emerged.
EUS-guided transvascular fine-needle aspiration (EUS-TV-
FNA) has been described as a feasible and generally safe alter-
native approach in selected patients if other proven methods
entail greater potential morbidity and no other target is avail-
able. This statement is based on small case series and retro-
spectives studies; to date, little is known about when EUS-TV-
FNA can be recommended [4].
The primary aim of this multicenter study was to analyze the
diagnostic yield and safety of EUS-TV-FNA in thoracic and ab-
dominal lesions. Secondary aims were to assess the clinical im-
pact and technical aspects of the procedure.
Patients and methods
A retrospective multicenter study was designed, consisting of
examination of a nationwide database involving all Spanish hos-
pitals experienced in EUS-TV-FNA. All members of the Spanish
Group of Endoscopic Ultrasound were invited by mail to partici-
pate (89 endoscopists). Six centers participated. The inclusion
period ran from July 2007 to January 2020. Inclusion criteria
were all EUS-TV-NA performed during the inclusion period. Ex-
▶ Fig. 1 a,b A suspicious mediastinal lymph node located behind the left pulmonary artery, close to the aorto-pulmonary window. c A 25-G
needle crossing the major vessel; the tip of the needle is seen in the target. d Doppler flow is detected in the pulmonary artery during the
puncture.
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clusion criteria were coagulopathy, portal hypertension, and
lack of follow-up information. The following variables were re-
viewed: demographic details, clinical data, staging imaging,
procedure and technical details, cytological data, medication
with potential risk of bleeding, follow-up data, incidents, and
AEs. All imaging parameters were reviewed and taken from the
original written reports.
Technique
All patients provided written informed consent before the pro-
cedure. All EUS-TV-FNA were performed by five experienced en-
dosonographers (JCS, JRA, CDS, EVS, and JBG), each of whom
had more than 15 years of experience in interventional EUS).
Deep sedation was provided by a non-anesthesiologist or an an-
esthesiologist, depending on each center’s protocol. For pa-
tients with antiplatelet or anticoagulant therapy, the recom-
mendations of the international guidelines were followed [5].
Antibiotic prophylaxis was considered depending on each cen-
ter’s protocol.
Based on available imaging information, including the same-
day EUS study, transvascular access was regarded as the only
option to diagnose or stage these cases. The transvascular ap-
proach was considered only when the pathological information
to be obtained would have an impact on the clinical plan, and it
was subject to approval by a multidisciplinary committee.
A linear array echoendoscope (GF-UCT140-AL5, GF-UC160P-
OL5 or GF-UCT180, Olympus; EG3870UTK, Pentax; or EG-
580UT, Fujifilm) was used to identify and puncture the target
lesion. Prior to transvascular puncture, technical attempts
were made to avoid an intravascular route (e. g., deflecting the
tip or changing scope position). In the transaortic cases, a spe-
cial effort was made to avoid intraluminal aortic plaques. Color
Doppler imaging was used to avoid interposal vessels and to
identify major vascular structures. The target was identified,
and the needle was advanced, traversing the vessel until the
tip was seen inside the lesion, and then the stylet was removed.
The suction technique applied, if any (stylet slow-pull vs. stand-
ard suction), was applied, and needle type and size were select-
ed at the discretion of the endosonographer (25 or 22G; Echo-
Tip Ultra-HD, Cook or Expect Slimline, Boston Scientific). Fan-
ning technique was avoided. The number of passes was deter-
▶ Fig. 2 a Abdominal lymph node suggestive of lymphoma with the inferior cava vein interposed. b Doppler effect in the cava vein.
c, d A transcaval endoscopic-guided puncture with a 22-G needle is performed.
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mined by the quantity of material or the presence of the cyto-
pathology team.
Examples of different EUS-guided transvascular approaches
are presented in ▶Fig. 1 and ▶Fig. 2, and Fig. S1).
At the end of the procedure, the needle was retracted, and
the para-vascular area was observed for 2 minutes to assess po-
tential immediate procedure-related AEs.
Samples were prepared with rapid on-site evaluation (ROSE)
or without, depending on each center’s protocol. All patients
were monitored in the recovery room of the endoscopy unit
for at least 6 hours, and at the discretion of each center were
discharged or admitted for 24-hour clinical observation. No
routine chest or abdominal imaging was done after the proce-
dure.
AEs were defined and graded according to the ASGE lexicon
severity grading system [6].
Statistical analysis
Categorical variables were described by the number of cases,
percentages, and missing data. Continuous variables were de-
scribed by the number of cases, mean and standard deviation,
or the median and the interquartile range (IQR). Categorical
variables were compared using the chi-squared test. Quantita-
tive variables were compared using the student’s t test. Univari-
ate analysis was performed to identify variables associated with
incidents, cytopathological diagnoses and clinical impact. Mul-
tivariate analysis using multiple logistic regression was per-
formed on predictor variables with a P <0.05.
Sensitivity, specificity, diagnostic accuracy, negative predic-
tive value (NPV), and positive predictive value (PPV) were calcu-
lated. Positive biopsies were treated as true positive. Cases with
non-representative material were considered as false nega-
tives.
Diagnostic performance was considered as total amount of
conclusive cytopathology results (malignancy plus benignity)
excluding inconclusive results (atypical, suspected, or insuffi-
cient samples).
The level of statistical significance was set at < 0.05. The sta-
tistical package used was SPSS version 22.0.
Results
Demographics
A total of 49 cases and 50 EUS-TV-FNA were collected, with a
mean age of 64 years (SD 10.6); more than half were men
(54%). Demographic and clinical characteristics are shown in
▶Table 1.
Intrabdominal lesions were the most common targets (n =
28), and the aorta (n=19) and portal system (n=17) the vessels
most frequently punctured. Information related to types of ves-
sels, target lesions, and their respective anatomical regions are
summarized in ▶Table 2.
Interventional procedures
In all 50 procedures, real-time visualization of the needle tra-
versing the vessel and into the target was technically feasible
and aspiration was applied in all. Most instances of deep seda-
tion were controlled by anaesthesiologists (68%), and the ma-
jority of patients were discharged after a period of observation
of at least 6 hours (58%). All centers except two contributed
more than five cases. The median number of cases per center
was 8.3 (range 1–18).
Endoscopist suspicion of malignancy, based on the EUS im-
age, was the most common finding (70%), and the most fre-
quent final diagnoses were malignant mediastinal lymph nodes
▶Table 1 Clinical and demographic characteristics.
Variables Data
n=49 patients/50 procedures
Age, mean (SD) 64.4 (10.6)
Sex, n (%) male/female
▪ Men 27 (54), 23 (46.9)
CCI, mean (SD)  5.16 (2.64)
No comorbidities, n (%)  9 (18)
Cardiovascular risk factors, n (%) 32 (64)
Chronic pulmonary disease, n (%)  9 (18)
Cardiovascular diseases, n (%) 12 (24)
Chronic kidney disease, n (%)  4 (8)
Coagulopathy, n (%)  1 (2)
Active neoplasia, n (%)  7 (14)
Antithrombotic drugs, n (%)
▪ Antiplatelet 12 (24.4)
▪ Oral anticoagulant  0 (0)
ASA classification, n (%)
▪ I  5 (10)
▪ II 22 (44)
▪ III 23 (46)
▪ IV  0 (0)
Sedative agents, n (%)
▪ Propofol 39 (78)
▪ Fentanyl +midazolam 11 (22)
Sedation carried out by:
▪ Non-anesthesiologist 16 (32)
▪ Anesthesiologist 34 (68)
Inpatient treatment, n (%)
▪ 6 hours observation in recovery room 29 (58)
▪ 24-hour admission to hospital 16 (32)
▪ Breakthrough admission  5 (10.2)
▪ Antibiotic prophylaxis, n (%) 19 (38)
ASA, American Society of Anesthesiologists; CCI, Charlson Comorbidity
Index; SD, standard deviation.
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(n = 13), pancreatic tumours (n=11) and lung cancer (n =8).
Mean (SD) of target diameter and distance to the target were
24mm (14) and 21.3mm (SD9.7) respectively. More data relat-
ed to the EUS findings and final diagnoses are presented in
▶Table 3.
Technical aspects of FNA: needle size, 22 and 25G (52% and
48% respectively); aspiration technique, suction-syringe and
slow-pull (44% and 58% respectively); median number of pas-
ses was two (interquartile range: 1.0 to 8.0). Other technical
aspects of EUS-TV-FNA, including pathological and safety re-
sults, are summarized in ▶Table4 and Table S1. The diagnostic
yield of EUS-TV-FNA was 86%, representing malignant plus be-
nign final results. Non-diagnostic samples were found in seven
cases; these included dysplasia (n =2), suspicious but not con-
clusive matter (n =2), and insufficient matter (n=3).
Intraluminal aorta plaques were found in three cases and
changing the position of the scope was undertaken to avoid
the plaques.
Diagnostic performance
A positive cytological diagnosis of malignancy was confirmed
in 36 cases. Two suspected cytological diagnoses were con-
firmed as true positive with progression on follow-up imaging.
Benign cytological results (n =7) were confirmed by surgical
biopsy (n =1) and regression/stability on follow-up imaging
procedures. Three insufficient samples were considered as
false negative. The number of total false negatives rose to
five, including two cases of pancreatic cystic tumors (dysplasia
by cytological diagnosis). Only one considered false negative
was confirmed as malignancy despite an insufficient sample
with EUS (abdominal mass, diagnosed as lymphoma by percu-
taneous-guided biopsy in another more accessible point). The
rest of false negatives were confirmed due to progression or
suspicious behaviour in follow-up imaging tests The overall
sensitivity, specificity, positive and negative predictive value,
and accuracy were 88% (95%CI, 74–96), 100% (95%CI, 59–
100), 100% (95%CI, 88–100), 58% (95%CI, 38–76) and 90%
(95%CI, 78–96) respectively (Table S2).
Safety
No AEs occurred, either during procedures or in the post-proce-
dural period. Only three incidents were encountered. Two mi-
nor mural hematomas (aorta and pulmonary artery) were de-
tected on EUS images immediately after a transvascular FNA.
Self-limited bleeding after the EUS-guided puncture of a gas-
troduodenal artery was observed in a patient with antiplatelet
therapy. None of these patients were symptomatic.
Twelve patients were treated with antiplatelet therapy with-
out any additional cases of bleeding or hematomas. Antibiotic
prophylaxis was administered in 38% of patients, and no cases
of fever or infection related to the procedure were reported.
Clinical impact
Only in six cases did EUS-TV-FNA not cause a change in the glo-
bal management of the patients. In most cases (88%), the in-
terventional procedure directly impacted the clinical manage-
ment of the patient.
▶Table 2 Vessels, target lesions, and respective anatomical regions.
Vessels Target Locations
THORAX1 ABDOMINAL2
Mediastinum Lung Pancreas Non-pancreatic Adrenal Total
▪ Arterial vessel
n = 29
Aorta 14 3  13 18
Pulmonary artery  4  4
Superior mesenteric artery  2  2
Hepatic artery  1  1
Splenic artery  2  1  3
Gastroduodenal artery  1  1
▪ Venous vessel
n = 20
Porta  9  3 12
Superior mesenteric vein  1  4  5
Inferior vena cava  1 1  2
Azygos  1  1
Splenic vein  1  1
Total 19 3 17 10 1 50
1 Thorax lesions included mediastinal masses, lymph nodes, and lung masses.
2 Abdominal lesions: pancreatic tumors, non-pancreatic tumors, pancreatic cyst, lymph nodes,and right adrenal lesion.
3 Peripancreatic lymph node
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Univariate and multivariate analysis
An arterial vessel and ASA III had a significant trend with inci-
dents related to transvascular puncture. No significant factors
were found to be related in clinical impact. Univariate analysis
of incidents and final diagnoses is summarized in ▶Table 4 and
Table S3. On multivariate analysis, ROSE (OR6.2; 95%CI, 1.063–
36.737, P<0.043) was found to be an independent predictor of
obtaining a conclusive sample for a final diagnosis.
Discussion
Since Vincent et al and Wallace et al (2006 and 2007, respec-
tively) published papers on the first transvascular (pulmonary
artery and aorta) puncture guided by EBUS and EUS, respective-
ly, only a few case reports and small case series have been pub-
lished [7, 8]. Much of the current literature on EUS-TV-FNA has
paid special attention to intrathoracic lesions, and most of the
knowledge about this technique comes from the EBUS field [9–
12]. Many of the reports related to EUS-guided FNA involve the
transaortic approach and focus on the study of lung cancer [4,
8, 13–15]. Other vascular interventions have included EUS-
guided portal access for diagnostic or therapeutic purposes in
sampling for hepatocellular carcinoma and portal embolization
[16–19].
To our knowledge, this is the first study of EUS-TV-FNA com-
bining experience with intrathoracic and intrabdominal lesions
and traversing different types of vessels with a considerable
range of sample sizes. In the present study, a total of 50 trans-
vasculars biopsies were taken, guided by EUS, and using 22-G
and 25-G needles with an average of two passes. Intrabdominal
lesions were more frequent targets than thoracic lesions, with
the thoracic aorta and porta the most frequently traversed ves-
sels.
An updated literature review is included (▶Table5), and
three retrospective case series stand out for comparison to our
results [4, 8, 9, 11–16, 20, 21].
Bartheld et al. performed 14 transaortic EUS-FNA in the di-
agnosis of mediastinal LN and lung tumors, using 25-G needles
and a single pass. They reported a diagnostic yield of 71% and
two hematomas (14%) at the site of aortic puncture, without
clinical consequences [4].
Wang et al. reported 26 transportal system EUS-guided
transgastric procedures in diagnosing pancreatic tumours,
using a 22-G needle, with an average of four passes, and a sen-
▶Table 3 Endoscopic ultrasound findings and diagnosis.
Characteristics Total, n-50
EUS findings:
▪ Diameter of the target, mean (SD), mm 24.4 (14.0)
▪ Missing  6 (12.2)
▪ Distance to the transducer, mean (SD), mm 21.2 (9.4)
▪ Missing 10 (20.4)
Echo pattern n (%)
▪ Homogeneous 20 (40.8)
▪ Heterogeneous 29 (59.2)
Endoscopist suspicion, n (%)
▪ Benignity  6 (12.2)
▪ Malignancy 34 (69.4)
▪ Undetermined  9 (18.4)
Final diagnosis, n (%):
▪ Pancreatic adenocarcinoma 13 (26.5)
▪ Metastases (LN and masses) 11 (22.4)
▪ Lung cancer (LN and masses)  8 (16.3)
▪ Mucinous pancreatic cyst  4 (8.2)
▪ Benignity  3 (6.1)
▪ Lymphoma  2 (4.1)
▪ Others1  5 (10.2)
▪ Unrepresentative  3 (6.1)
EUS, endoscopic ultrasound; SD, standard deviation; LN, lymph nodes.
1 Cholangiocarcinoma (1), lung adenocarcinoma (1), serous pancreatic cyst
(1), pancreatic pseudocyst (1), neuroendocrine tumour (1), granuloma (1).
▶Table 4 Univariate analysis of potential factors related to cyto-
pathological diagnosis.
Variables Data P value1
Age, mean (SD) 64.4 (10.6) 0.05
Procedure time, median (IQR) 30 (24–75) 0.08
FNA passes, median (IQR)  2 (1–8) 0.51
Needle size, n (%) 0.04
▪ 25-G 26 (52)
▪ 22-G 25 (51.0)
ROSE2, n (%) 0.02
▪ Yes 33 (66)
▪ No 17 (34.7)
FNA technique, n (%) 0.64
▪ Slow-pull (no syringe) 27 (54)
▪ Suction-syringe 21 (42.9)
▪ Others  2 (4.1)
EUS suspicious, n (%) 0.17
▪ Benignity  6 (12.2)
▪ Malignancy 35 (70)
▪ Undetermined  9 (18.4)
FNA, fine needle aspiration; IQR, interquartile range; ROSE, rapid-on site
evaluation; SD, standard deviation.
1 P obtained with student’s t-test and chi-squared test. Statistical signifi-
cance at P<0.05
2 Half of centers (n-3) had ROSE available.
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sitivity and accuracy of 91% and 92%, respectively, without any
AEs. The authors argued that the lower portal pressure compar-
ed with aortic pressure could explain why no hematomas were
detected [16].
Recently, Molina et al. reported 65 cases of EUS-FNA, plus
35 EBUS cases of transvascular-guided biopsies of intrathorac-
ic lesions, with the aorta the most common vessel traversed.
The authors used a 22-G needle, with an average of two passes
per target, and obtained an overall sensitivity and accuracy of
71.5% and 74.5%, respectively. No immediate AEs were re-
ported, and only one delayed aortic pseudoaneurysm. One
possible explanation for this lower diagnostic performance is
that the number of passes made in a transvascular approach
is less than with standard EUS-FNA, and this might affect sam-
ple adequacy [12].
The diagnostic yield of our study was higher than in other
studies. This may be because an average of two attempts
(range: 1–8) at transvascular FNA was made and ROSE was pos-
sible in most cases. Concretely, all transaortic cases, and all
transportal cases except one, yielded a final diagnosis. On uni-
variate analysis we found that a 25-G needle and ROSE were sig-
nificantly related to obtaining a final diagnosis, but only ROSE
was significant on the multivariate analysis. The fact that our
endoscopists had extensive experience in the EUS-guided FNA
technique surely contributed to these results.
In terms of safety, to date the reported AE rate in transvas-
cular biopsies taken with EUS or EBUS guidance seems to be
low and without fatal events. In the radiological literature, a
rate of 0.05% major AEs related to translumbar aortography is
reported, but asymptomatic mural hematomas are not uncom-
mon [1–3]. To our knowledge, three immediate hematomas
have been described after transaortic punctures guided by
EUS, without the need for interventional therapy. One case of
pseudo-aneurysm was detected 3 weeks after a transaortic
EUS-FNA that was managed conservatively [4, 8, 12].
In our study, no AEs were detected, and three incidents were
reported: two hematomas after transaortic EUS-FNA using a
25-G needle (2 passes), and one self-limited bleed after a gas-
troduodenal puncture using a 22-G needle (2 passes). No inter-
ventional procedures were required to manage these incidents.
An arterial vessel and ASA III were almost significantly related to
incidents, and no other factors were found to be related. Cur-
▶Table 5 Transaortic, transcarotid, transportal, and transcaval endoscopic ultrasound-guided fine-needle aspiration. A literature review.
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iously, none of the transaortic cases with more than two passes
was associated with incidents or AEs. Given these data, and
their congruence with previously reported hematomas with
transaortic approaches, we should offer a word of caution, and
suggest that FNA should only be performed in the absence of
alternative means to obtain a tissue diagnosis for para-aortic le-
sions.
Therefore, from a technical point of view, it seems reason-
able to recommend, whenever possible, the use of 25-G nee-
dles and ROSE in these types of interventional procedures,
especially in arteries, without limit to a single pass.
However, some questions remain: Does the use of thinner
needle (25-G) really reduce the risk of bleeding? And does in-
creasing the number of passes carry a greater risk of tumor
seeding? To address these questions and their concerns, pro-
spective studies are needed.
Finally, in addition to broad knowledge of echo-anatomy in
the EUS field, a transvascular approach requires skills and ex-
pertise in the FNA technique. In our opinion, the degree of chal-
lenge depends on the vessel size. Crossing a splenic vessel and
crossing the aorta with a needle are not the same. A transaortic
or trans-pulmonary artery scenario must be recognized as
being of greater complexity. The distance between the lesion
and the tip of scope may be greater than 5 cm and predicting
needle trajectory requires experience. The procedure should
be performed by endoscopists with proven experience and
with a favourable balance of benefits/risks.
Limitations
This study has some limitations, mainly owing to its retrospec-
tive design. First, variation between centers with a potential
population bias cannot be excluded. Second, the variability of
target lesions and different anatomical location of the vessels
included in this study may have imposed a selection bias on
the study population. Third, the lack of a standardized protocol
with no specific follow-up implies a lack of information missing
on follow-up, associated with a possible failure to catch some
AEs.
Conclusions
This interventional technique is feasible and seems to be safe.
The balance between diagnostic benefit and safety must be
weighed. It is likely that a 25-G needle and ROSE may be recom-
mended, especially in arteries; an endoscopic transvascular ap-
proach should be considered when no other locations are pos-
sible for taking samples in selected patients.
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